** Medical device maker's shares IRMD.O fall as much as
7.4 pct to $23.9
** Co expects a 2 pct drop in FY 2019 revenue on temporary
suspension of sales of its 3880 MRI compatible patient vital
signs monitors in European Commission markets, due to CE Mark
expiration urn:newsml:reuters.com:*:nGNX74V3Bn
** Says the suspension does not impact product sales in the
US and other markets that do not require CE Mark for importing
** Expects to resolve the matter before the end of second
quarter
** IRMD climbed 61.5 pct in 2018
(Reporting by Manogna Maddipatla)
((Reuters Messaging:
manojna.kalyani.thomsonreuters.com@reuters.net))